Cipla has reported results for first quarter ended June 30, 2023 (Q1FY24).
Cipla has reported 17.90% rise in net profit at Rs 895.02 crore for the quarter ended June 30, 2023 as compared to Rs 759.16 crore for the same quarter in the previous year. Total income of the company increased by 12.93% at Rs 4,476.17 crore for Q1FY24 as compared Rs 3,963.82 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 41.34% rise in its net profit at Rs 998.07 crore for the quarter under review as compared to Rs 706.14 crore for the same quarter in the previous year. Total income of the company increased by 18.01% at Rs 6,465.18 crore for Q1FY24 as compared Rs 5,478.62 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1532.85 |
Dr. Reddys Lab | 5812.50 |
Cipla | 1403.90 |
Zydus Lifesciences | 1104.45 |
Lupin | 1661.90 |
View more.. |